Characteristic | Unadjusted OR (95% CI) | Adjusted OR (95% CI) * |
---|---|---|
Age(years) | ||
< 65 | 1.0 | 1.0 |
> 65 | 5.70 (3.28–9.92) | 2.31 (1.13–4.73) |
Medical insurance coverage | ||
High (> 70%) | 1.0 | 1.0 |
Medium (50–70%) | 2.36 (1.28–4.36) | 3.21 (1.53–6.73) |
Low (< 50%) | 2.86 (1.44–5.66) | 3.58 (1.57–8.15) |
Family history | ||
Negative | 1.0 | |
Positive | 1.24 (0.47–3.24) | |
Marital status | ||
Married | 1.0 | |
Unmarried | 2.20 (0.93–5.19) | |
Employment status | ||
Employed | 1.0 | |
Unemployed | 1.15 (0.58–2.28) | |
Retired | 0.77 (0.42–1.41) | |
Tumor size (cm) | ||
0–1.9 | 1.0 | |
2–4.9 | 1.28 (0.79–2.09) | |
> 5 | 2.44 (0.89–6.68) | |
Positive axillary nodal status | ||
0 | 1.0 | |
1–3 | 1.15 (0.68–1.94) | |
4–9 | 1.74 (0.82–3.69) | |
> 10 | 1.47 (0.55–3.96) | |
TNM stage | ||
Stage 0-I | 1.0 | |
Stage II | 1.17 (0.70–1.95) | |
Stage III | 1.44 (0.73–2.83) | |
Histological subtype | ||
In Situ | 1.0 | |
Ductal/Lobular/Mixed/Metaplastic | 0.49 (0.11–2.08) | |
Tubular/Mucinous/Papillary | 0.13 (0.01–1.54) | |
ER | ||
Negative | 1.0 | |
Positive | 1.32 (0.79–2.20) | |
PR | ||
Negative | 1.0 | |
Positive | 1.24 (0.76–2.01) | |
HER2 | ||
Negative | 1.0 | |
Positive | 0.84 (0.47–1.52) | |
Surgery of breast | ||
Lumpectomy | 1.0 | |
Mastectomy | 1.37 (0.86–2.18) | |
Axillary surgery | ||
Sentinel lymph node biopsy | 1.0 | 1.0 |
Axillary lymph node dissection | 1.57 (0.97–2.53) | 2.51 (1.39–4.52) |
Chemotherapy | ||
Yes | 1.0 | 1.0 |
No | 5.27 (3.19–8.70) | 3.48 (1.84–6.57) |
Radiotherapy | ||
Yes | 1.0 | 1.0 |
No | 5.32 (3.25–8.71) | 3.90 (2.14–7.10) |
Targeted therapy | ||
Yes | 1.0 | |
No | 3.24 (1.13–9.28) | |
Endocrine therapy | ||
Yes | 1.0 | |
No | 1.65 (1.03–2.64) |